Enabling reliable skin drug delivery and patient comfort

Our solution – VAX-ID an intradermal injection adaptor

VAX-ID® is the heart of Idevax, an ISO13485:2016 certified company. It is an award-winning patented drug delivery device suited for reliable intradermal injection with high ease of use.

VAX-ID® is CE marked as a Class IIa medical device, meeting the stringent European Medical Device Regulations for products sold within the European Economic Area (EEA). For other regions, devices are currently available for investigational use only (IUO) and research use only (RUO). 

Benefits VAX-ID

Watch how the device works

Our skin – an overlooked optimal site for skin drug delivery and immunization

Skin drug delivery or intradermal injection (i.e. injection in the dermal layer of the skin) offers great benefits for both prophylactic and therapeutic vaccines.  Why? The skin is our first line of defense offering a dense network of immune cells. Indeed, for prophylactic vaccines there is a clear dose-sparing potential as only 1/10th of the dose is needed compared to intramuscular and subcutaneous administration. Also, the rich immune network offers beneficial benefits for therapeutic drug delivery, including cell therapy and cancer immunotherapy.

Latest news:

Meet Elisabed Gelashvili — Our New QARA Intern at IDEVAX

International Day of Women and Girls in Science: Highlighting Women in Advanced Therapies 

Highlights 2025

Highlights of 2025

Events:

Belgian Dermatology Days 2026

Advanced Therapies 2026

Bio-Europe

Bio-Europe